Olympus (TSE:7733) Cyclically Adjusted Revenue per Share: 円727.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7733 Olympus Corp TSE:7733
75 GF Score
Price 円1,813.50
GF Value 円2,608.77
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus Cyclically Adjusted Revenue per Share?

Olympus TSE:7733 +4.86% 75 Cyclically Adjusted Revenue per Share is 円727.28 as of Mar. 2026. GuruFocus rates TSE:7733 with a GF Score™ of 75/100 and a GF Value™ of 円2,608.77 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Olympus's adjusted revenue per share for the three months ended in Mar. 2026 was 円265.083. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円727.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Olympus's average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Olympus was 5.90% per year. The lowest was -4.20% per year. And the median was -2.15% per year.

As of today (2026-07-27), Olympus's current stock price is 円1813.50. Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円727.28. Olympus's Cyclically Adjusted PS Ratio of today is 2.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Olympus was 5.19. The lowest was 1.12. And the median was 2.88.


Olympus  (TSE:7733) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Olympus's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1813.50/727.28
=2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Olympus was 5.19. The lowest was 1.12. And the median was 2.88.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Olympus Cyclically Adjusted Revenue per Share Related Terms


Olympus Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Olympus's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus Cyclically Adjusted Revenue per Share Chart

Olympus Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 597.60 613.08 645.89 693.87 727.28

Olympus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 693.87 700.36 707.10 720.51 727.28

TSE:7733 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Olympus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Olympus's Cyclically Adjusted PS Ratio falls into.


TSE:7733
75GF Score
Olympus Corp TSE:7733
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olympus Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Olympus's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=265.083/112.7000*112.7000
=265.083

Current CPI (Mar. 2026) = 112.7000.

Olympus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 123.134 98.100 141.460
201609 131.516 98.000 151.243
201612 133.659 98.400 153.083
201703 152.446 98.100 175.134
201706 125.476 98.500 143.565
201709 144.265 98.800 164.561
201712 147.989 99.400 167.790
201803 156.901 99.200 178.253
201806 132.217 99.200 150.210
201809 147.325 99.900 166.201
201812 145.789 99.700 164.799
201903 155.759 99.700 176.069
201906 133.126 99.800 150.334
201909 149.711 100.100 168.556
201912 150.013 100.500 168.224
202003 150.756 100.300 169.394
202006 106.295 99.900 119.914
202009 139.826 99.900 157.742
202012 153.224 99.300 173.901
202103 168.677 99.900 190.289
202106 148.896 99.500 168.649
202109 150.264 100.100 169.178
202112 145.486 100.100 163.799
202203 159.087 101.100 177.340
202206 150.942 101.800 167.104
202209 176.351 103.100 192.772
202212 176.855 104.100 191.465
202303 191.412 104.400 206.630
202306 165.361 105.200 177.150
202309 183.423 106.200 194.649
202312 199.744 106.800 210.779
202403 213.079 107.200 224.011
202406 201.119 108.200 209.483
202409 207.042 108.900 214.267
202412 221.716 110.700 225.722
202503 237.356 111.100 240.774
202506 182.831 111.700 184.468
202509 221.503 112.000 222.887
202512 236.543 113.000 235.915
202603 265.083 112.700 265.083

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円727.28 mean?
Olympus (TSE:7733) has a Cyclically Adjusted Revenue per Share of 円727.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Olympus and its competitors.
Is Olympus' Cyclically Adjusted Revenue per Share too high?
Olympus' current Cyclically Adjusted Revenue per Share is 円727.28. Overall, Olympus has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Olympus' Cyclically Adjusted Revenue per Share of 円727.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Olympus and its competitors. Olympus's current Cyclically Adjusted Revenue per Share is 円727.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,608.77, compared to a current price of 円1,813.50 — trading 30.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円727.28. Olympus' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Olympus (TSE:7733), the current Cyclically Adjusted Revenue per Share is 円727.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olympus (TSE:7733) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of 円1,813.50 is trading 30.5% below its estimated GF Value™ of 円2,608.77. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for TSE:7733:

  • Cyclically Adjusted Revenue per Share: 円727.28
  • GF Value™: 円2,608.77 vs. price of 円1,813.50 (30.5% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
75GF Score

Get the complete analysis for TSE:7733

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,813.50
Price
円2,608.77
GF Value